Real-time monitoring of FDA, EMA, MHRA, and health regulators worldwide. AI-powered alerts for drug approvals, guidance changes, and enforcement actions.
Start Free Trial →FDA's CBER is issuing new guidance monthly on cell and gene therapies. One missed update can delay your IND submission by quarters.
FDA, EMA, PMDA, MHRA — each with different timelines, different requirements, different formats. Your RA team can't manually track them all.
FDA Warning Letters are published online. Your competitors, investors, and partners see them. Prevention costs 0.1% of remediation.
New drug approvals, 483 observations, warning letters, guidance drafts, and final rules — all in one feed, AI-summarized daily.
FDA, EMA, MHRA, PMDA, Health Canada, TGA — monitor regulatory changes across every major pharma market simultaneously.
Oncology? Rare disease? Medical devices? Filter by your therapeutic area and only see regulations that affect your pipeline.
IND, NDA, BLA, 510(k) — track every submission deadline with automated reminders. Never miss a filing window.
Track competitor FDA interactions — approval timelines, CRLs, advisory committees. Know the landscape before your next board meeting.
Built with pharma compliance in mind. Audit trails, export controls, and data handling that your QA team will approve.
14-day free trial. No credit card required. Covers FDA, EMA, and 13 more agencies.
Start Free Trial →